Peter Rieckmann

Costs and quality of life in multiple sclerosis

Peter Lindgren, Uwe K. Zettl, P. Rieckmann, 2001, The European Journal of Health Economics (HEPAC).

Monocyte/macrophage differentiation in early multiple sclerosis lesions

Hans Lassmann, Wolfgang Brück, W. Brück, 1995, Annals of neurology.

New perspectives in the natural history of multiple sclerosis

Michael Hutchinson, Helen Tremlett, Yinshan Zhao, 2010, Neurology.

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

Helen Tremlett, P. Rieckmann, H. Tremlett, 2010, Journal of the Neurological Sciences.

Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care

Gavin Giovannoni, Sven Schippling, Dawn Langdon, 2019, Advances in Therapy.

Future MS care: a consensus statement of the MS in the 21st Century Steering Group

Jacques LeLorier, Sven Schippling, D. Centonze, 2012, Journal of Neurology.

Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.

Gavin Giovannoni, Sven Schippling, Dawn Langdon, 2018, Multiple sclerosis and related disorders.

Refining genetic associations in multiple sclerosis

Hanne F. Harbo, Margaret A. Pericak-Vance, Stephen L. Hauser, 2008, The Lancet Neurology.

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Bernhard Hemmer, Ludwig Kappos, Xavier Montalban, 2013, The Lancet Neurology.